Close

BIO Comments on Tissue Agnostic Therapies in Oncology: Regulatory Considerations for Orphan Drug Designation

June 8, 2018

...

Clinical Trials: Scientific and Ethical Considerations for Inclusion in Clinical Trials

June 8, 2018

...

BIO 2018 Makes History in Boston

Boston, MA – (June 7, 2018) – The 2018 BIO International Convention (BIO 2018) today wrapped up four days of programming under the theme of “Make History.” Hosted by the Biotechnology Innovation Organization(BIO), BIO 2018 attracted thousands of U.S. and international attendees, celebrated innovations that have shaped the past 25 years and recognized the companies, patient groups, academic centers and investors that continue to advance novel solutions to the world’s toughest challenges...  

BIO Presents the Henri A. Termeer Biotechnology Visionary Award to Gates Foundation’s Dr. Sue Desmond-Hellmann

Washington, D.C. (June 6, 2018) – The Biotechnology Innovation Organization (BIO) is pleased to announce the establishment of the Henri A. Termeer Biotechnology Visionary Award – created in honor of the late Genzyme CEO who was instrumental in transforming Boston into a thriving hub of life science research, development and innovation... 

BIO Sets the GUINNESS WORLD RECORDS™ Title for the Largest Business Partnering Event

Washington, DC (June 6, 2018) – This morning at the Biotechnology Innovation Organization’s (BIO) International Convention in Boston, BIO proudly attempted – and set– the GUINNESS WORLD RECORDS title for the Largest Business Partnering Event.

South Dakota Governor Dennis Daugaard Presented BIO Lifetime Champion Award

Boston, MA (June 6, 2018) –  The Biotechnology Innovation Organization (BIO) presented South Dakota Governor Dennis Daugaard with a Lifetime Champion...

Massachusetts Governor Charlie Baker Presented 2018 BIO Governor of the Year Award

Boston, MA (June 5, 2018) –  The Biotechnology Innovation Organization (BIO) today presented Massachusetts Governor Charlie Baker...

BIO Elects New Board Directors and Section Governing Board Chairs

Boston, MA (June 5, 2018) – The Biotechnology Innovation Organization (BIO) is pleased to announce the election of 11 new board directors and several new section governing board chairs and vice chairs at the 2018 BIO International Convention.

National Bioscience Industry Report Shows $2T Economic Impact, Accelerated Venture Capital Investment & Job Growth

A study released today at the BIO International Convention shows that the U.S. bioscience industry has reached $2 trillion in annual economic impact while maintaining accelerated venture capital investment and job growth numbers. Among U.S. technology sectors, the bioscience industry has held a leading position as an economic driver and job generator.

New Bioscience Report Shows Record-Breaking Economic Impact, Accelerated Venture Capital Investment & Job Growth

BIO’s latest report shows that the U.S. bioscience industry has reached record setting annual economic impact, venture capital investment and job growth numbers. Among U.S. technology sectors, the bioscience industry is a leading economic driver and job generator across the U.S., with job growth in 41 states.